1 - 6 of 6 Results
Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.
A pressure burst feature has been designed and demonstrated for relieving potentially hazardous excess pressure within irradiation capsules used in the ORNL High Flux Isotope Reactor (HFIR).
Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.
Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.
The invention ensures post-validation calibrated physics system predictions remain within predetermined model validation domain boundaries.
An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence